2020 IPO
AbCellera Biologics Stock
Antibody therapeutics
Sign up today and learn more about AbCellera Biologics Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About AbCellera Biologics Stock
AbCellera Biologics offers development of antibody therapeutics to improve patient outcomes.
Funding History
| September 2013 | $0 |
|---|---|
| August 2014 | $0 |
| January 2017 | $0 |
| April 2017 | $818K |
| September 2018 | $10.0M |
| March 2019 | $4.8M |
Management
Co-Founder
Kevin Heyries
Co-Founder & Director
Véronique Lecault
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
